NanoViricides Inc (NYSEMKT:NNVC) shares dipped 2.61% on Wednesday to $1.12 and were unchanged in after-hours trading. Share prices have been trading in a 52-week range of $1.03 to $2.18. The company has a market cap of $72.89 million at 62.82 million shares outstanding. NanoViricides Inc is a nano-biopharmaceutical company with several drugs...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Audentes Therapeutics Inc. (NASDAQ:BOLD) reported that Flynn James E  has picked up 1,214,423 of common stock as of 2017-04-26. The acquisition brings the aggregate amount owned by Flynn James E to a total of 1,214,423...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Edge Therapeutics Inc. (NASDAQ:EDGE) reported that Satter Muneer A. has picked up 1,800,000 of common stock as of 2017-04-25. The acquisition brings the aggregate amount owned by Satter Muneer A. to a total of 1,800,000...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Tocagen Inc. (NASDAQ:TOCA)  reported that Foresite Capital Fund Iii, L.p. has picked up 915,000 of common stock as of 2017-04-25. The acquisition brings the aggregate amount owned by Foresite Capital Fund Iii, L.p. to a...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Nivalis Therapeutics Inc. (NASDAQ:NVLS) reported that Flynn James E has picked up 3,732,414 of common stock as of 2017-04-25. The acquisition brings the aggregate amount owned by Flynn James E to a total of 3,732,414...